Middle Peak Medical said it raised an $8.5 million Series A round to develop its technology for mitral valve replacement.
The Palo Alto, Calif.- and Munich-based medical device company said the round was co-led by Wellington Partners and Seventure Partners, joined by prior backer High-Tech Gründerfonds Management.
Middle Peak said it will keep its research & development operations in Palo Alto and establish clinical and regulatory operations in Europe.